Products

RT-Mind-AI
MedMind Technology Co., Ltd.
Oncology AI
RT-Mind-AI is a product that outlines over 120 Organ-at-Risk throughout the body, designed for intelligent analysis of medical imaging datasets in radiotherapy.

See all 1 product →

About MedMind Technology Co.

Medmind Technology Limited is an innovative healthcare AI company dedicated to promoting healthy aging, with a primary focus on the prevention, monitoring, and intervention of dementia and other mental health disorders in seniors. Their flagship product, NeuroGym, is an interactive, gamified cognitive training platform. This platform leverages research-based, elderly-friendly exercises, often incorporating local cultural elements like Mahjong and calligraphy, to engage users actively and continuously.

For physicians, NeuroGym offers a valuable tool for personalized cognitive training, longitudinal disease monitoring, and early screening for cognitive decline. It provides detailed reports that enable healthcare professionals and caregivers to effectively track user progress, assess conditions, and implement timely interventions. The company also develops PhysioPlay for gamified physical training. Medmind Technology’s overarching mission is to reduce the stigma associated with mental health disorders, enhance disease awareness, and facilitate early detection and treatment, thereby contributing to a more socially-inclusive community for the elderly.

What Physicians Need to Know

Cognitive Health & Early Detection
Specializes in the early detection and monitoring of cognitive decline and brain diseases, particularly dementia, through innovative AI-powered tools.
Gamified Brain Training
Transforms traditional medical assessments into engaging, gamified brain training experiences, making cognitive health assessments more accessible and less intimidating for seniors.
AI-Powered Data Analysis
Utilizes an AI backend for precise data analysis, measuring subtle metrics like reaction times and thought processes to predict early dementia risks and personalize training.
Student Mental Health
Expanding its focus to address student mental health and pressure management, indicating a broader application of its AI technology beyond elderly care.
Physician Tip

For physicians, MedMind Technology's NeuroGym offers a unique approach to cognitive assessment and intervention. Leverage its gamified nature to increase patient engagement and compliance, especially among seniors who may find traditional clinical tests intimidating. The AI-driven backend provides objective, quantifiable data on cognitive function, including reaction times and thought processes, which can be invaluable for early detection of cognitive impairment and dementia risk. This allows for timely medical intervention when it is most effective. Utilize the detailed reports generated by the platform to track patient progress longitudinally and inform personalized care plans. The system's ability to adjust difficulty levels in real-time can also help maintain patient motivation during training.

MedMind Technology has successfully integrated its solutions into NGO networks and healthcare facilities within Hong Kong.

Products by MedMind Technology Co.

1 product in the directory

RT-Mind-AI
MedMind Technology Co., Ltd.
Oncology AI
RT-Mind-AI is a product that outlines over 120 Organ-at-Risk throughout the body, designed for intelligent analysis of medical imaging datasets in radiotherapy.

What the Web Says

MedMind Technology Co. is a company specializing in AI-powered solutions for radiation therapy planning, particularly in auto-contouring and image enhancement. Their product, RT-Mind-AI, is deployed in over 360 hospitals and has NMPA Class III and FDA 510(k) clearance. The company's technology aims to improve the accuracy and efficiency of radiotherapy workflows by automating the delineation of organs-at-risk (OARs) and clinical target volumes (CTVs).

Overall: Positive

Strengths

  • Significant time-saving in contouring workflow (92.5% average time saving).
  • Supports over 120 OARs and CTV delineation across multiple cancer types.
  • Deployed in over 360 hospitals with NMPA Class III and FDA 510(k) clearance.
  • Adaptive learning capabilities to user's individual techniques.
  • Improved consistency in contouring and streamlining radiotherapy workflows.
  • High accuracy in auto-segmentation, with some models outperforming manual delineation by certain clinicians.

Limitations

  • Potential for less accurate auto-contouring with different CT slice thicknesses than those used for model training.
  • Difficulty in dealing with artifacts caused by pacemakers and contrast-injected CT images.
  • Some clinicians may have higher expectations for delineation results, leading to inter-observer variability in evaluations.
  • No significant correlation found between image similarity metrics and dose accuracy, emphasizing the need for dose evaluation when assessing clinical applicability.

Based on reviews from: DLinRT, accessdata.fda.gov, Research and Markets, Innolitics, Spandidos Publications, Sheet1 (Google Search Result), Radboud Repository, Taylor & Francis Online, DOI (Digital Object Identifier), Frontiers, ResearchGate, PMC (PubMed Central)

Last updated: 2026-07-19

Videos

News, demos, and interviews about MedMind Technology Co..

Loading videos...

Videos load interactively. If none appear, search YouTube for MedMind Technology Co. →

View all on YouTube

Press & Coverage

MedMind Technology Co., Ltd. Official Website
Double Certification Approved! MedMind's Radiation Therapy AI Software Receives FDA Market Authorization.
MedMind's radiation therapy AI software, RT-Mind-AI, has received FDA market authorization, indicating its approval for use in the United States. This product is designed for auto-contouring of organs-at-risk and clinical target volumes in radiation therapy.
2021-12
MedMind Technology Co., Ltd. Official Website
MedMind's Radiation Therapy Contouring Product Approved for NMPA Class III Certification, Empowering Precision Treatment for Cancer.
MedMind's radiation therapy contouring product has been approved for NMPA Class III Certification in China, signifying its high-level regulatory clearance for medical devices. This certification allows the company to further empower precision cancer treatment.
2021-12
MedMind Technology Co., Ltd. Official Website
Advancing Precision Medicine: Collaboration between Peking Union Medical College, Tsinghua University, and MedMind.
MedMind Technology has partnered with Peking Union Medical College and Tsinghua University to advance precision medicine. This collaboration likely focuses on research and development in AI-driven healthcare solutions.
unknown
MedMind Technology Co., Ltd. Official Website
AI-Enhanced Target Area Mapping for Precision Navigation in Tumor Treatment.
MedMind Technology is developing AI-enhanced target area mapping for precision navigation in tumor treatment. This technology aims to improve the accuracy and effectiveness of radiation therapy.
2021-06
PubMed (Radiotherapy and Oncology)
Development and validation of a deep learning algorithm for auto-delineation of clinical target volume and organs at risk in cervical cancer radiotherapy
This peer-reviewed article details the development and validation of a deep learning algorithm by MedMind Technology Co. for automatic delineation of clinical target volume and organs at risk in cervical cancer radiotherapy. The study, published in Radiotherapy and Oncology, demonstrates the algorithm's effectiveness.
2020-10
Taylor & Francis (Cancer Management and Research)
Automatic Segmentation of Clinical Target Volume and Organs-at-Risk for Breast Conservative Radiotherapy Using a Convolutional Neural Network
This peer-reviewed research, with authors affiliated with MedMind Technology Co., presents a convolutional neural network for automatic segmentation of clinical target volume and organs-at-risk in breast conservative radiotherapy. The study highlights the efficiency and accuracy of the AI-powered tool.
2021-11
Frontiers in Oncology
Artificial intelligence in automatic image segmentation system for exploring recurrence patterns in small cell carcinoma of the lung
This article, co-authored by individuals from MedMind Technology Co., discusses the use of artificial intelligence in an automatic image segmentation system to explore recurrence patterns in small cell carcinoma of the lung. The research aims to improve prognosis prediction and clinical guidance.
2025-05
Spandidos Publications (Oncology Letters)
Clinical evaluation of the convolutional neural networku2011based automatic delineation tool in determining the clinical target volume and organs at risk in rectal cancer radiotherapy
A clinical evaluation of MedMind Technology Co.'s convolutional neural network-based automatic delineation tool (RT-Mind version 1.1) for determining clinical target volume and organs at risk in rectal cancer radiotherapy is presented in this journal article. The study, supported by Henan Province Science and Technology Development Project, demonstrates the tool's high acceptability in clinical practice.
2024-09

Frequently Asked Questions

MedMind Technology Co. provides AI-powered solutions focused on enhancing clinical decision support, optimizing administrative workflows, and improving patient outcomes through predictive analytics. Our product suite includes tools for diagnostic assistance, operational efficiency, and personalized treatment recommendations, designed to integrate seamlessly into existing healthcare ecosystems.
MedMind Technology Co. prioritizes regulatory compliance by implementing robust data encryption, access controls, and privacy protocols to meet HIPAA and GDPR standards. Our clinical AI tools undergo rigorous validation processes and are developed in alignment with FDA guidelines for medical device software, seeking appropriate clearances and certifications where applicable to ensure safety and efficacy.
Our pricing model is generally subscription-based, often tiered according to the scale of deployment, number of users, or specific modules and features utilized. We offer flexible options including annual contracts and enterprise-level agreements, with transparent cost structures. Custom quotes are provided after a detailed needs assessment to align with your organization's specific requirements and budget.
MedMind Technology Co. offers comprehensive support packages, including dedicated technical assistance available during business hours and 24/7 for critical issues. We provide extensive onboarding training for clinical and IT staff, along with regular software updates, performance monitoring, and proactive maintenance. Our goal is to ensure seamless integration, optimal performance, and continuous value from our AI solutions.
Yes, our AI solutions are designed for seamless integration with major EHR systems through standard APIs and established interoperability protocols to ensure data flow and workflow efficiency. We actively pursue strategic partnerships with leading healthcare technology providers, academic institutions, and industry innovators. These collaborations enhance our offerings and ensure compatibility within diverse healthcare environments.
MedMind Technology Co. was founded in 2018 and has rapidly grown into a recognized leader in healthcare AI, backed by significant venture capital funding and strategic investors. We have a strong track record of successful deployments in various healthcare systems, demonstrating our commitment to long-term innovation and stability. Our robust financial health supports continuous research and development to meet evolving industry needs.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.